Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

271 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Aromatase, 17 beta-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women.
Vermeulen A, Deslypere JP, Paridaens R, Leclercq G, Roy F, Heuson JC. Vermeulen A, et al. Among authors: paridaens r. Eur J Cancer Clin Oncol. 1986 Apr;22(4):515-25. doi: 10.1016/0277-5379(86)90121-5. Eur J Cancer Clin Oncol. 1986. PMID: 3015631
Inhibitory action of androstenedione on the proliferation and cell cycle kinetics of aromatase-free MXT and MCF-7 mammary tumour cell lines.
Kiss R, de Launoit Y, Wouters W, Deslypere JP, Lescrainier JP, Paridaens R, Vokaer A, Decoster R, Pasteels JL. Kiss R, et al. Among authors: paridaens r. Eur J Cancer Clin Oncol. 1989 May;25(5):837-43. doi: 10.1016/0277-5379(89)90129-6. Eur J Cancer Clin Oncol. 1989. PMID: 2737220
Endocrine effects of Trilostane: in vitro and in vivo studies.
Tueni E, Devleeschouwer N, Leclercq G, Nijs M, Coune A, Vermeulen A, Paridaens R. Tueni E, et al. Among authors: paridaens r. Eur J Cancer Clin Oncol. 1987 Oct;23(10):1461-7. doi: 10.1016/0277-5379(87)90087-3. Eur J Cancer Clin Oncol. 1987. PMID: 2824205
Steroid dynamics in the normal and carcinomatous mammary gland.
Vermeulen A, Deslypere JP, Paridaens R. Vermeulen A, et al. Among authors: paridaens r. J Steroid Biochem. 1986 Nov;25(5B):799-802. doi: 10.1016/0022-4731(86)90311-0. J Steroid Biochem. 1986. PMID: 3027457
Cisplatin plus vindesine in advanced breast cancer: a phase II trial of the EORTC Breast Cancer Cooperative Group.
Paridaens R, Clarysse A, Rozencweig M, Rotmensz N, Heuson JC. Paridaens R, et al. Eur J Cancer Clin Oncol. 1985 May;21(5):595-9. doi: 10.1016/0277-5379(85)90087-2. Eur J Cancer Clin Oncol. 1985. PMID: 4040025
Carminomycin versus doxorubicin in advanced breast cancer, a randomized phase II study of the E.O.R.T.C. Breast Cancer Cooperative Group.
Van Oosterom AT, Mouridsen HT, Wildiers J, Paridaens R, Cocconi G, Rotmensz N, Sylvester R. Van Oosterom AT, et al. Among authors: paridaens r. Eur J Cancer Clin Oncol. 1986 May;22(5):601-5. doi: 10.1016/0277-5379(86)90050-7. Eur J Cancer Clin Oncol. 1986. PMID: 3770031 Clinical Trial.
An overview of the EORTC Breast Cancer Cooperative Group's activities.
Paridaens R, Mattheiem WH, van Dongen JA, Mouridsen HT, Rotmensz N, Sylvester R. Paridaens R, et al. Eur J Cancer Clin Oncol. 1983 Dec;19(12):1665-9. doi: 10.1016/0277-5379(83)90149-9. Eur J Cancer Clin Oncol. 1983. PMID: 6363087 Clinical Trial. No abstract available.
Salvage therapy in advanced breast cancer.
Paridaens RJ. Paridaens RJ. Eur J Cancer Clin Oncol. 1985 Dec;21(12):1443-7. doi: 10.1016/0277-5379(85)90236-6. Eur J Cancer Clin Oncol. 1985. PMID: 3830725 No abstract available.
Sensitivity of the hormone dependent MXT-mouse mammary carcinoma to estradiol during tumoral growth. An autoradiographic study.
Kiss R, Paridaens R, Leclercq G, Danguy A. Kiss R, et al. Among authors: paridaens r. Eur J Cancer Clin Oncol. 1986 Jul;22(7):849-56. doi: 10.1016/0277-5379(86)90373-1. Eur J Cancer Clin Oncol. 1986. PMID: 3770041
Advanced breast cancer--new approaches to treatment: workshop report.
Mouridsen HT, Paridaens R. Mouridsen HT, et al. Among authors: paridaens r. Eur J Cancer Clin Oncol. 1988 Jan;24(1):99-105. doi: 10.1016/0277-5379(88)90184-8. Eur J Cancer Clin Oncol. 1988. PMID: 2448147 Review. No abstract available.
271 results
Jump to page
Feedback